Table 1
Demographic, clinical and laboratory characteristics of coronary slow flow and control groups
| Parameter | Coronary slow flow (n = 92) | Control group (n = 90) | p value |
|---|---|---|---|
| Age (years) | 55.1 ± 9.4 | 53.6 ± 8.9 | 0.268 |
| Male gender, n (%) | 59 (64.1) | 56 (62.2) | 0.782 |
| Hypertension, n (%) | 41 (44.6) | 38 (42.2) | 0.742 |
| Diabetes mellitus, n (%) | 29 (31.5) | 26 (28.9) | 0.697 |
| Smoking status, n (%) | 45 (48.9) | 42 (46.7) | 0.768 |
| TG (mg/dL) | 171 (142–198) | 136 (112–163) | <0.001 |
| HDL-C (mg/dL) | 40.2 ± 7.9 | 46.1 ± 8.6 | <0.001 |
| LDL cholesterol (mg/dL) | 121.4 ± 32.6 | 116.8 ± 30.9 | 0.341 |
| Total cholesterol (mg/dL) | 198.6 ± 41.3 | 191.2 ± 39.8 | 0.214 |
| Atherogenic index | 0.56 ± 0.19 | 0.43 ± 0.17 | <0.001 |
| MPV (fL) | 10.2 ± 0.8 | 9.6 ± 0.7 | <0.001 |
| Platelet count (×103/µL) | 248 ± 61 | 242 ± 58 | 0.481 |
| TIMI frame count | 29.1 ± 4.3 | 18.7 ± 3.8 | <0.001 |